News
- Author:
- Amy Karon
Publish date: May 23, 2016
Patients who have persistent leukocytosis or persistent systemic inflammatory response syndrome on the day of scheduled cholecystectomy may have un...
News
- Author:
- Amy Karon
Publish date: May 22, 2016
A 15-mg daily dose of mirtazapine controlled comorbid functional dyspepsia and psychological distress more effectively than placebo.
News
- Author:
- Amy Karon
Publish date: May 22, 2016
A disposable Endocuff cut colonoscopic withdrawal times by nearly a minute and slightly improved polyp detection.
News
- Author:
- Amy Karon
Publish date: May 21, 2016
Stevens-Johnson syndrome and toxic epidermal necrolysis are not quite as rare as previously thought.
News
- Author:
- Amy Karon
Publish date: May 21, 2016
Key clinical point: The annual incidence of SJS was 8.6-9.8 cases per million adults per year, with a mean of 9.3 cases.
Major finding: The annual...
News
- Author:
- Amy Karon
Publish date: May 20, 2016
Key clinical point: One course of topical 5-fluorouracil was effective and durable in preventing new actinic keratoses in high-risk patients.
Majo...
News
- Author:
- Amy Karon
Publish date: May 16, 2016
Key clinical point: Psoriasis is an independent risk factor for serious infections, and serious infections are increasing among inpatients with ps...
News
- Author:
- Amy Karon
Publish date: May 16, 2016
Key clinical point: Psoriasis is an independent risk factor for serious infections, and serious infections are increasing among inpatients with ps...
News
- Author:
- Amy Karon
Publish date: May 14, 2016
Key clinical point: The topical phosphodiesterase-4 inhibitor crisaborole was safe and well tolerated for up to 48 weeks in patients with mild-to-...
News
- Author:
- Amy Karon
Publish date: May 13, 2016
Key clinical point: Thalidomide, methotrexate, dapsone, and belimumab may be the best alternatives for patients whose cutaneous lupus erythematosu...
News
- Author:
- Amy Karon
Publish date: May 13, 2016
Key clinical point: Thalidomide, methotrexate, dapsone, and belimumab may be the best alternatives for patients whose cutaneous lupus erythematosu...
News
- Author:
- Amy Karon
Publish date: May 11, 2016
Key clinical point: Epstein-Barr virus DNA was a more specific indicator of EBV+ diseases when detected in plasma, as opposed to peripheral blood m...
News
- Author:
- Amy Karon
Publish date: April 29, 2016
Key clinical point: Treating multiple myeloma cells with panobinostat and FK506 reduced their viability by inhibiting expression of the PPP3CA cat...
News
- Author:
- Amy Karon
Publish date: April 28, 2016
Key clinical point: The risk of transformation to diffuse large B-cell lymphoma is low in patients with nodular lymphocyte–predominant Hodgkin lymp...
News
- Author:
- Amy Karon
Publish date: April 26, 2016
